P. Kleihues, D.N. Louis, O.D. Wiestler, P.C. Burger, B.W. Scheithauer. WHO grading of tumours of the central nervous system. David N. Louis, Hiroko Ohgaki, Otmar D. Wiestler, Webster K. Cavenee. WHO Classification of Tumours of the Central Nervous System. 4th. International Agency for Research on Cancer (IARC); 2007. 10.
Quinn T. Ostrom, Haley Gittleman, Paul Farah, Annie Ondracek, Yanwen Chen, Yingli Wolinsky, et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010. Neuro-Oncology. November/2013. 15:ii1-ii56. [QxMD MEDLINE Link].
Emanuele Crocetti, Annalisa Trama, Charles Stiller, Adele Caldarella, Riccardo Soffietti, Jana Jaal, et al. Epidemiology of glial and non-glial brain tumours in Europe. European Journal of Cancer. 2012. 48:1532-1542. [QxMD MEDLINE Link].
Julius Griauzde, Ahmad Khaldi, Edward Melian, Ricarchito Manera, Margaret Primeau, Darrin M. Aase, et al. Pilocytic Astrocytojma: A Comprehensive Review. Contemporary Neurosurgery. June 30, 2011. 33:1-6.
Fleury A, Menegoz F, Grosclaude P, et al. Descriptive epidemiology of cerebral gliomas in France. Cancer. 1997 Mar 15. 79(6):1195-202. [QxMD MEDLINE Link].
Nader Pouratian, Ahok Asthagiri, Jay Jagannathan, Mark E Shaffrey, David Schiff. Surgery Insight: the role of surgery in the management of low-grade gliomas. Nature Clinical Practice. Neurology. November/2007. 3:628-639. [QxMD MEDLINE Link].
Hiroko Ohgaki, Paul Kleihues. Epidemiology and etiology of gliomas. Acta Neuropathologica. 2005. 109:93-108. [QxMD MEDLINE Link].
C. Bettegowda, M. Sausen, R. J. Leary, I. Kinde, Y. Wang, N. Agrawal, et al. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies. Science Translational Medicine. February/2014. 6:1-11. [QxMD MEDLINE Link].
Ajlan A, Recht L. Supratentorial low-grade diffuse astrocytoma: medical management. Semin Oncol. 2014 Aug. 41(4):446-57. [QxMD MEDLINE Link].
Lunsford LD, Somaza S, Kondziolka D, Flickinger JC. Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. J Neurosurg. 1995 Apr. 82(4):523-9. [QxMD MEDLINE Link].
Recht LD, Bernstein M. Low-grade gliomas. Neurol Clin. 1995 Nov. 13(4):847-59. [QxMD MEDLINE Link].
Pedersen CL, Romner B. Current treatment of low grade astrocytoma: a review. Clin Neurol Neurosurg. 2013 Jan. 115(1):1-8. [QxMD MEDLINE Link].
Sanai N, Snyder LA, Honea NJ, Coons SW, Eschbacher JM, Smith KA, et al. Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas. J Neurosurg. 2011 Oct. 115(4):740-8. [QxMD MEDLINE Link].
Christian Senft, Andrea Bink, Kea Franz, Harmut Vatter, Thomas Gasser, Volker Seifert. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncology. 2011. 12:997-1003. [QxMD MEDLINE Link].
Chang EF, Clark A, Smith JS, Polley MY, Chang SM, Barbaro NM. Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article. J Neurosurg. 2011 Mar. 114(3):566-73. [QxMD MEDLINE Link].
Sanai N, Mirzadeh Z, Berger MS. Functional outcome after language mapping for glioma resection. N Engl J Med. 2008 Jan 3. 358(1):18-27. [QxMD MEDLINE Link].
Chang EF, Clark A, Jensen RL, Bernstein M, Guha A, Carrabba G, et al. Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. J Neurosurg. 2009 Aug. 111(2):203-10. [QxMD MEDLINE Link].
Kim YH, Nobusawa S, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K. Molecular classification of low-grade diffuse gliomas. Am J Pathol. 2010 Dec. 177(6):2708-14. [QxMD MEDLINE Link].
Alvord EC, Lofton S. Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment. J Neurosurg. 1988 Jan. 68(1):85-98. [QxMD MEDLINE Link].
Clark GB, Henry JM, McKeever PE. Cerebral pilocytic astrocytoma. Cancer. 1985 Sep 1. 56(5):1128-33. [QxMD MEDLINE Link].
Constantini S, Houten J, Miller DC, et al. Intramedullary spinal cord tumors in children under the age of 3 years. J Neurosurg. 1996 Dec. 85(6):1036-43. [QxMD MEDLINE Link].
Duffau H, Lopes M, Arthuis F, Bitar A, Sichez JP, Van Effenterre R. Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry. 2005 Jun. 76(6):845-51. [QxMD MEDLINE Link].
Franzini A, Leocata F, Cajola L, Servello D, Allegranza A, Broggi G. Low-grade glial tumors in basal ganglia and thalamus: natural history and biological reappraisal. Neurosurgery. 1994 Nov. 35(5):817-20; discussion 820-1. [QxMD MEDLINE Link].
Hakyemez B, Erdogan C, Ercan I, et al. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol. 2005 Apr. 60(4):493-502. [QxMD MEDLINE Link].
Komotar RJ, Mocco J, Carson BS, et al. Pilomyxoid astrocytoma: a review. MedGenMed. 2004. 6(4):42. [QxMD MEDLINE Link].
Laws ER, Taylor WF, Clifton MB, Okazaki H. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg. 1984 Oct. 61(4):665-73. [QxMD MEDLINE Link].
Lote K, Egeland T, Hager B, et al. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol. 1997 Sep. 15(9):3129-40. [QxMD MEDLINE Link].
Macdonald DR. Low-grade gliomas, mixed gliomas, and oligodendrogliomas. Semin Oncol. 1994 Apr. 21(2):236-48. [QxMD MEDLINE Link].
McCormack BM, Miller DC, Budzilovich GN, et al. Treatment and survival of low-grade astrocytoma in adults--1977-1988. Neurosurgery. 1992 Oct. 31(4):636-42; discussion 642. [QxMD MEDLINE Link].
McCormick PC, Stein BM. Spinal cord tumors in adults. Neurological Surgery. 1996. 4:3102-122.
Morantz R A. Low-grade astrocytomas. Kaye AH, Laws ER Jr, eds. Brain Tumors: An Encyclopedic Approach. New York: Churchill Livingstone; 1995. 433-48.
Salcman M. Radical surgery for low-grade glioma. Clin Neurosurg. 1990. 36:353-66. [QxMD MEDLINE Link].
Teixidor P, Gatignol P, Leroy M, Masuet-Aumatell C, Capelle L, Duffau H. Assessment of verbal working memory before and after surgery for low-grade glioma. J Neurooncol. 2007 Feb. 81(3):305-13. [QxMD MEDLINE Link].
Vandenberg SR, Sampaio Lopes MB. Classification. Berger MS, Wilson CB, eds. The Gliomas. Philadelphia: WB Saunders; 1999. 172-91.
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016 Jun. 131 (6):803-20. [QxMD MEDLINE Link].
Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. Neuro Oncol. 2016 Oct 1. 18 (suppl_5):v1-v75. [QxMD MEDLINE Link].
Buckner J, Giannini C, Eckel-Passow J, Lachance D, Parney I, Laack N, et al. Management of diffuse low-grade gliomas in adults - use of molecular diagnostics. Nat Rev Neurol. 2017 Jun. 13 (6):340-351. [QxMD MEDLINE Link].
Reuss DE, Kratz A, Sahm F, Capper D et al. Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathol. 2015 Sep. 130 (3):407-17. [QxMD MEDLINE Link].
Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25. 372 (26):2481-98. [QxMD MEDLINE Link].
Jenkins RB, Blair H, Ballman KV, Giannini C et al. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res. 2006 Oct 15. 66 (20):9852-61. [QxMD MEDLINE Link].
Eckel-Passow JE, Lachance DH, Molinaro AM et al. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med. 2015 Jun 25. 372 (26):2499-508. [QxMD MEDLINE Link].
Lassaletta A, Zapotocky M, Bouffet E, Hawkins C, Tabori U. An integrative molecular and genomic analysis of pediatric hemispheric low-grade gliomas: an update. Childs Nerv Syst. 2016 Oct. 32 (10):1789-97. [QxMD MEDLINE Link].
Duffau H, Taillandier L. New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach. Neuro Oncol. 2015 Mar. 17 (3):332-42. [QxMD MEDLINE Link].
Delgado-López PD, Corrales-García EM, Martino J et al. Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies. Clin Transl Oncol. 2017 Aug. 19 (8):931-944. [QxMD MEDLINE Link].
Wessels PH, Weber WE, Raven G, Ramaekers FC, Hopman AH, Twijnstra A. Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol. 2003 Jul. 2 (7):395-403. [QxMD MEDLINE Link].
Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg. 2008 Feb. 108 (2):227-35. [QxMD MEDLINE Link].
Leone MA, Giussani G, Nolan SJ, Marson AG, Beghi E. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure. Cochrane Database Syst Rev. 2016 May 6. CD007144. [QxMD MEDLINE Link].
D'Amico RS, Englander ZK, Canoll P, Bruce JN. Extent of Resection in Glioma-A Review of the Cutting Edge. World Neurosurg. 2017 Jul. 103:538-549. [QxMD MEDLINE Link].
Gerin C, Pallud J, Deroulers C, Varlet P, Oppenheim C et al. Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomas. Neuro Oncol. 2013 Oct. 15 (10):1379-88. [QxMD MEDLINE Link].
Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006 May. 7 (5):392-401. [QxMD MEDLINE Link].
Moiyadi AV, Shetty PM, Mahajan A, Udare A, Sridhar E. Usefulness of three-dimensional navigable intraoperative ultrasound in resection of brain tumors with a special emphasis on malignant gliomas. Acta Neurochir (Wien). 2013 Dec. 155 (12):2217-25. [QxMD MEDLINE Link].
Solheim O, Selbekk T, Jakola AS, Unsgård G. Ultrasound-guided operations in unselected high-grade gliomas--overall results, impact of image quality and patient selection. Acta Neurochir (Wien). 2010 Nov. 152 (11):1873-86. [QxMD MEDLINE Link].
D'Amico RS, Kennedy BC, Bruce JN. Neurosurgical oncology: advances in operative technologies and adjuncts. J Neurooncol. 2014 Sep. 119 (3):451-63. [QxMD MEDLINE Link].
Delgado-López PD, Corrales-García EM, Martino J, Lastra-Aras E et al. Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies. Clin Transl Oncol. 2017 Aug. 19 (8):931-944. [QxMD MEDLINE Link].
Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR, Barger GR, et al. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. N Engl J Med. 2016 Apr 7. 374 (14):1344-55. [QxMD MEDLINE Link].
Duffau H, Taillandier L. New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach. Neuro Oncol. 2015 Mar. 17 (3):332-42. [QxMD MEDLINE Link].
Delgado-López PD, Corrales-García EM, Martino J, Lastra-Aras E, Dueñas-Polo MT. Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies. Clin Transl Oncol. 2017 Aug. 19 (8):931-944. [QxMD MEDLINE Link].
Upadhyaya SA, Ghazwani Y, Wu S, Broniscer A, Boop FA, Gajjar A, et al. Mortality in children with low-grade glioma or glioneuronal tumors: A single-institution study. Pediatr Blood Cancer. 2017 Jul 14. [QxMD MEDLINE Link].
Perilongo G. Considerations on the role of chemotherapy and modern radiotherapy in the treatment of childhood low grade glioma. J Neurooncol. 2005 Dec. 75 (3):301-7. [QxMD MEDLINE Link].
Chalil A, Ramaswamy V. Low Grade Gliomas in Children. J Child Neurol. 2016 Mar. 31 (4):517-22. [QxMD MEDLINE Link].
Mistry M, Zhukova N, Merico D, Rakopoulos P, Krishnatry R et al. BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma. J Clin Oncol. 2015 Mar 20. 33 (9):1015-22. [QxMD MEDLINE Link].
Rumana CS, Valadka AB. Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas. Neurosurgery. 1998 May. 42 (5):1038-43. [QxMD MEDLINE Link].
Brinkman TM, Liptak CC, Delaney BL, Chordas CA, Muriel AC, Manley PE. Suicide ideation in pediatric and adult survivors of childhood brain tumors. J Neurooncol. 2013 Jul. 113 (3):425-32. [QxMD MEDLINE Link].
Suzuki Y, Takahashi-Fujigasaki J, Akasaki Y, Matsushima S, Mori R et al. BRAF V600E-mutated diffuse glioma in an adult patient: a case report and review. Brain Tumor Pathol. 2016 Jan. 33 (1):40-9. [QxMD MEDLINE Link].
Lassaletta A, Zapotocky M, Mistry M, Ramaswamy V, Honnorat M et al. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas. J Clin Oncol. 2017 Sep 1. 35 (25):2934-2941. [QxMD MEDLINE Link].
Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T et al. Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncol. 2016 Nov. 17 (11):1521-1532. [QxMD MEDLINE Link].
Grossman R, Shimony N, Shir D, Gonen T, Sitt R, Kimchi TJ, et al. Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival. Ann Surg Oncol. 2017 Mar. 24 (3):794-800. [QxMD MEDLINE Link].
Le Rhun E, Taillibert S, Chamberlain MC. Current Management of Adult Diffuse Infiltrative Low Grade Gliomas. Curr Neurol Neurosci Rep. 2016 Feb. 16 (2):15. [QxMD MEDLINE Link].